Navigation Links
Micromet and MedImmune Present Data From Preclinical Study of New,BiTE Molecule Targeting CEA

egulatory approval or that, even if regulatory approval is received, any such product will be commercially successful. MedImmune undertakes no obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise except as may be required by applicable law or regulation.

Forward-Looking Statements of Micromet, Inc.

This release contains certain forward-looking statements that involve risks and uncertainties that could cause actual results to be materially different from historical results or from any future results expressed or implied by such forward-looking statements. Such forward-looking statements include statements regarding the intended utilization of product candidates, the conduct and results of future clinical trials, plans regarding regulatory filings, future research, discovery of new product candidates, and clinical trials, and partnering activities. Factors that may cause actual results to differ materially include the risk that product candidates that appeared promising in early research and clinical trials do not demonstrate safety and/or efficacy in larger-scale or later clinical trials, the risks associated with regulatory processes, the risks associated with reliance on outside financing to meet capital requirements, and the risks associated with reliance on collaborative partners for future revenues under the terms of its existing collaboration agreements, and for further pre-clinical and clinical studies, development and commercialization of product candidates. You are urged to consider statements that include the words "appear," "may," "will," "would," "could," "should," "believes," "estimates," "projects," "potential," "expects," "plans," "anticipates," "intends," "continues," "forecast," "designed," "goal," or the negative of those words or other comparable words to be uncertain and forward-looking. These factors and others are more fully discussed in Micromet's periodic reports a
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Micromet, Inc. to Present at the 3rd Annual C.E. Unterberg, Towbin Emerging Growth Conference
2. Publication Confirms that EpCAM, the Target for Two of Micromets Product Candidates, Is Overexpressed on Cancer Stem Cells of Certain Cancers
3. Micromet Achieves Milestone in BiTE Research Collaboration with MedImmune
4. MedImmune and Micromet Publish Data on Novel Anti-Cancer BiTE Molecule
5. Infinity and MedImmune Present Updated Phase I Results of IPI-504 in GIST at ASCO Annual Meeting
6. Infinity and MedImmune Announce Updated Data On Ipi-504 to be Presented At ASCO
7. MedImmune Highlights Advances in Inflammatory Disease Pipeline With Series of Data Presentations
8. MedImmune Announces Positive Clinical Results at PAS Annual Meeting From Large Prospective Trial in Prevention of Serious RSV Disease
9. Pediatric Academic Societies Annual Meeting to Feature Data Presentations Related to MedImmune Clinical Programs in Influenza, RSV and hMPV
10. MedImmune Publishes New Data in Nature Immunology Demonstrating The Role HMGB1 May Play in Systemic Autoimmune Diseases
11. Infinity and MedImmune to Present Preclinical Data From Study of Oral Formulation of IPI-504 At AACR
Post Your Comments:
(Date:5/27/2015)... 2015  With Freudenberg Xpress, Freudenberg-NOK Sealing ... machined seals from the original materials used ... have the same material characteristics and life ... products, can be made-to-order individual parts intended ... runs. The agenda is always: ordered, machined ...
(Date:5/27/2015)... N.J. , May 27, 2015  The ... LLC, utilizes a Motion Systems Corporation ball drive ... freedom. Motion Systems manufactures the industry,s largest selection ... to a wide array of industries, including medical ... help people who are wheelchair-bound as well as ...
(Date:5/27/2015)... SAN JOSE, Calif. , May ... Inc. (NASDAQ: MXIM ) makes ... medical sensor and to monitor or ... with the DS28E80 gamma-radiation-resistant, nonvolatile (NV) ... Details for DS28E80: http://www.maximintegrated.com/en/products/digital/memory-products/DS28E80.html ...
Breaking Medicine Technology:Xpress Service from Freudenberg-NOK Quickly Delivers Made-to-Order Sealing Solutions to Customers 2Innovative Technology Liberates the Wheelchair-Bound 2Gamma-Radiation-Resistant Memory Provides Calibration and Protects from Unsanitary Reuse in Medical Disposables 2Gamma-Radiation-Resistant Memory Provides Calibration and Protects from Unsanitary Reuse in Medical Disposables 3
... CareFusion Corporation (NYSE: CFN ) today announced plans to release third ... close of trading on the New York Stock Exchange. , ... The company will host a webcast and conference call on May 6 ... to discuss the results for its third quarter, ended on March 31, 2010 ...
... April 27 Kincannon & Reed Global Executive Search, a growing ... to the newly created position of Managing Director, Biopharmaceutical Life Sciences, effective ... , , ... this important new position. We recognize how important it is for our ...
Cached Medicine Technology:CareFusion Will Host an Earnings Conference Call on May 6 to Discuss the Results for the Third Quarter of Fiscal 2010 2Kincannon & Reed Names David G. Jensen as Managing Director, Biopharma Life Sciences 2
(Date:5/27/2015)... 27, 2015 NOVAtime Technology, Inc. ... Management solutions for enterprise organizations, announced today that ... to automate its time, attendance and point tracking ... in the United States. , Family-owned since ... of 21 retail, private label, and mill brands. ...
(Date:5/27/2015)... In support of a new study ... Journal of American Geriatrics Society about the link between ... Commons OB-GYN P.A . is reiterating the nutritional value ... , To examine the relationship between diet soda intake ... Study of Aging (SALSA) tracked the soda consumption of ...
(Date:5/27/2015)... (PRWEB) May 27, 2015 The ... announce a partnership to provide CMSA's Career and ... This collaboration seeks to strengthen the case/care management ... CMSA’s CKP program. The mutually beneficial agreement provides ... individual skills of talent in the healthcare, scientific ...
(Date:5/27/2015)... 27, 2015 SAN DIEGO, May ... Mississippi, is the first healthcare provider along the ... chronic care management (CCM). In partnership with MD ... introducing RevUp, a new program that enables healthcare ... increase monthly reimbursements. This new, user-friendly program is ...
(Date:5/27/2015)... 2015 CompanionDx announced that ... genomic analysis in personalized cancer therapy: Non-small cell lung ... Society of Clinical Oncology (ASCO) as part of their ... , The molecular and clinical data used for the ... database. The study reports improved patient outcomes from a ...
Breaking Medicine News(10 mins):Health News:SanMar Corporation Successfully Implemented NOVAtime Workforce Management Solution across 9 locations 2Health News:SanMar Corporation Successfully Implemented NOVAtime Workforce Management Solution across 9 locations 3Health News:Recent Study About the Link Between Diet Sodas and Abdominal Fat Reinforces Bedford Commons OB-GYN's Recommendation to Drink Plenty of Water 2Health News:Case Management Society of America Partners with Medix to Offer Career and Knowledge Pathways 2Health News:Case Management Society of America Partners with Medix to Offer Career and Knowledge Pathways 3Health News:Memorial Hospital Selects MD Revolution's Digital Health Platform to Deliver a New Form of Chronic Care Management 2Health News:Memorial Hospital Selects MD Revolution's Digital Health Platform to Deliver a New Form of Chronic Care Management 3Health News:CompanionDx® Analyzes Non-small Cell Lung Cancer Data for Personalized Cancer Therapy 2Health News:CompanionDx® Analyzes Non-small Cell Lung Cancer Data for Personalized Cancer Therapy 3
... New Guinea The southeast Pacific nation of ... biologically diverse ecosystems on Earth, has created its first ... pristine tropical forest larger than Singapore. , The decision ... with local communities neighboring the newly established YUS Conservation ...
... flu vaccine and flu vaccine supplies has unveiled their annual 2009 list ... ... (Vocus) March 2, 2009 -- Nationwide Medical/Surgical , a distributor of ... list of what to do if exposed to the flu virus., , ...
... The experiments, thus far performed only in mice, appear to ... of days, or even weeks, that it normally takes for ... vaccination could potentially be used to provide instantaneous protection against ... toxins. , The work is being published in the ...
... Pharmaceuticals, Inc. (Nasdaq: MAPP ) today announced financial ... 2008.The net loss for the fourth quarter ended December 31, ... same period in 2007. The net loss for the year ... million for the year ended December 31, 2007. MAP Pharmaceuticals ...
... BIRMINGHAM, Ala., March 2 HealthSouth Corporation (NYSE: ... the Barclays Capital Global Healthcare Conference on March 10-11, ... Beach, Fla.HealthSouth President and Chief Executive Officer Jay Grinney ... Workman will be speaking on Tuesday, March 10, at ...
... week away, study finds, , , MONDAY, March 2 (HealthDay News) ... children with mild persistent asthma begin to show dramatic changes ... March issue of Pediatrics reports that just seven ... for a rural area, airway inflammation went down and lung ...
Cached Medicine News:Health News:Papua New Guinea declares first national conservation area 2Health News:Papua New Guinea declares first national conservation area 3Health News:Papua New Guinea declares first national conservation area 4Health News:Nationwide Medical/Surgical Reveals Their Help Sheet For Those Infected with Influenza Virus 2Health News:Scripps research scientists engineer new type of vaccination that provides instant immunity 2Health News:Scripps research scientists engineer new type of vaccination that provides instant immunity 3Health News:MAP Pharmaceuticals Reports 2008 Fourth Quarter and Year End Financial Results 2Health News:MAP Pharmaceuticals Reports 2008 Fourth Quarter and Year End Financial Results 3Health News:MAP Pharmaceuticals Reports 2008 Fourth Quarter and Year End Financial Results 4Health News:MAP Pharmaceuticals Reports 2008 Fourth Quarter and Year End Financial Results 5Health News:MAP Pharmaceuticals Reports 2008 Fourth Quarter and Year End Financial Results 6Health News:MAP Pharmaceuticals Reports 2008 Fourth Quarter and Year End Financial Results 7Health News:City Kids Find the Breathin' Is Easier Elsewhere 2Health News:City Kids Find the Breathin' Is Easier Elsewhere 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: